Axoltis Pharma
Juliette LE DOUCE is an experienced Clinical Project Manager at Axoltis Pharma since September 2018, previously serving as a Preclinical R&D Project Manager. Prior to this role, Juliette worked as a postdoctoral researcher at Université de Genève from September 2016 to August 2018 and was a PhD candidate at CEA - Commissariat à l'énergie atomique et aux énergies alternatives from October 2012 to January 2016. Juliette's educational background includes a DIU in Clinical Drug Trials from Université Claude Bernard Lyon 1, a PhD in Neuroscience from Pierre and Marie Curie University, a Master's degree in Biology from École normale supérieure de Lyon, and a Bachelor's degree in Biology from Université Joseph Fourier (Grenoble I).
This person is not in any teams
Axoltis Pharma
Axoltis pharma is a biopharmaceutical company dedicated to develop a first-in-class disease-modifying drug to treat patients with neurodegenerative or traumatic neurological disorders with high unmet medical needs. Our innovative approach: combining Preventative, Neuroprotective, Regenerative & Remodeling properties in a single drug, as the key to cure complex neurological disorders. Our products are first-in-class multifunctional peptides with high potential in many CNS disorders.